Deep-learning segmentation to select liver parenchyma for categorizing hepatic steatosis on multinational chest CT.

Journal: Scientific reports
PMID:

Abstract

Unenhanced CT scans exhibit high specificity in detecting moderate-to-severe hepatic steatosis. Even though many CTs are scanned from health screening and various diagnostic contexts, their potential for hepatic steatosis detection has largely remained unexplored. The accuracy of previous methodologies has been limited by the inclusion of non-parenchymal liver regions. To overcome this limitation, we present a novel deep-learning (DL) based method tailored for the automatic selection of parenchymal portions in CT images. This innovative method automatically delineates circular regions for effectively detecting hepatic steatosis. We use 1,014 multinational CT images to develop a DL model for segmenting liver and selecting the parenchymal regions. The results demonstrate outstanding performance in both tasks. By excluding non-parenchymal portions, our DL-based method surpasses previous limitations, achieving radiologist-level accuracy in liver attenuation measurements and hepatic steatosis detection. To ensure the reproducibility, we have openly shared 1014 annotated CT images and the DL system codes. Our novel research contributes to the refinement the automated detection methodologies of hepatic steatosis on CT images, enhancing the accuracy and efficiency of healthcare screening processes.

Authors

  • Zhongyi Zhang
    Key Laboratory of Ministry of Education for Genetics, Breeding and Multiple Utilization of Crops, College of Agriculture, Fujian Agriculture and Forestry University, Fuzhou, China.
  • Guixia Li
    Department of Nephrology, Shenzhen Third People's Hospital, the Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, 518112, Guangdong, China.
  • Ziqiang Wang
    Research Center of Clinical Laboratory Science, Bengbu Medical University, Bengbu, China.
  • Feng Xia
  • Ning Zhao
  • Huibin Nie
    Department of Nephrology, Chengdu First People's Hospital, Chengdu, 610021, Sichuan, China.
  • Zezhong Ye
    Artificial Intelligence in Medicine (AIM) Program, Harvard Medical School, Boston, Massachusetts, USA.
  • Joshua S Lin
    Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.
  • Yiyi Hui
    Department of Medical Imaging, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. huiyiyi@sdfmu.edu.cn.
  • Xiangchun Liu
    Department of Nephrology, Multidisciplinary Innovation Center for Nephrology, The Second Hospital of Shandong University, Shandong University, Jinan, 250033, Shandong, China. liuxiangchun@sdu.edu.cn.